SESSION TITLE: Fellow Case Report Poster - Disorders of the Pleura
SESSION TYPE: Affiliate Case Report Poster
PRESENTED ON: Tuesday, October 25, 2016 at 01:30 PM - 02:30 PM
INTRODUCTION: Dasatinib, a tyrosine kinase inhibitor, is first line treatment for patients with Chronic Myelogenous Leukemia (CML). PAH and chylothorax are rare complications of Dasatinib and have not been reported to occur simultaneously. We report a patient with chylothorax and PAH after 4 years of Dasatinib use.